Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Revenue

Xilio Therapeutics had revenue of $8.08M in the quarter ending June 30, 2025, with 242.98% growth. This brings the company's revenue in the last twelve months to $15.00M, up 536.44% year-over-year. In the year 2024, Xilio Therapeutics had annual revenue of $6.34M.

• Revenue (ttm): $15.00M
• Revenue Growth: +536.44%
• P/S Ratio: 2.60
• Revenue / Employee: $234,391
• Employees: 64
• Market Cap: 40.07M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.34M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-